Bioidentical Hormones - U.S. Senate Special Committee on Aging

Bioidentical Hormones - U.S. Senate Special Committee on Aging Bioidentical Hormones - U.S. Senate Special Committee on Aging

aging.senate.gov
from aging.senate.gov More from this publisher
20.02.2013 Views

87 Dr. David Wright at Emory University Medical School in Atlanta has been testing compounded progesterone for head injury. In a 3year trial of 100 such patients, 80 received high-dose progesterone over 72 hours after trauma and 20 did not. The study on young men-not women-found that those receiving compounded progesterone were 50 percent less likely to die. There was less disability at the 1-month mark than would normally be expected considering the severity of their head injuries. Marcus Baskett of Commerce, GA, was one of those patients in a head-on automobile collision just 3 weeks shy of his high school graduation. Early tests of his brain function suggested massive and disabling head injury. He spent almost 3 weeks in a coma. Then, 4 weeks later, Baskett was released with lingering physical injuries but little evidence of the severe head trauma. Three years later, a 21-year-old Baskett is back 100 percent. There are uses for compounded bioidentical hormones that none of us have ever even imagined. To consider eliminating them is to limit the researchers' imagination everywhere. [The prepared statement of Ms. Wiley follows:]

88 Testimony Of T.S. Wiley before the ong>Specialong> ong>Committeeong> on Aging United States ong>Senateong> April 19, 2007 Mr. Chairman, Members of the ong>Committeeong>, I am T.S. Wiley and I would like to thank you for inviting me here today to share my expertise and experience with menopause and, of course bio-identical hormone replacement therapy and compounding pharmacy. I am a medical theorist in the field of Darwinian Medicine and writer/researcher on the use of hormones, particularly in postmenopausal women. I have devised and developed a new method of hormone replacement therapy (HRT) called the Wiley Protocol for women to use as a more accurate form of replacement for lost endocrine function. The remedies available to women suffering from hormone deficiency are woefully inadequate. The commercial pharmaceutical offerings are either bio-identical and too low in dosage to have efficacy, or synthetic drugs, far too dangerous to take. Here in the United States, there are over 40 million women between the ages of 40 and 60. Worldwide, about 25 million women enter menopause annually. It is estimated that by the year 2030, that number will increase to 47 million women per year. Since 1900, in the developed countries, the life expectancy of women has increase from age 47 to well over age 80, however, the average onset of menopause has remained at 50 as recorded for the last 150 years. That means, overall, women are living at least thirty years longer than they did at the turn of the century. Our society has never felt the impact of the majority of women living 30 or more years in a hormone deficient state. It won't be pretty. Right now, modem medicine keeps us propped up with antibiotics and surgery, thanks to blood transfusion and anesthesia. But just being alive does not assure "quality of life." Without it, extended lifespan is far less than a gift. It's estimated that eighty percent of women experience a variety of

87<br />

Dr. David Wright at Emory University Medical School in Atlanta<br />

has been testing compounded progester<strong>on</strong>e for head injury. In a 3year<br />

trial of 100 such patients, 80 received high-dose progester<strong>on</strong>e<br />

over 72 hours after trauma and 20 did not.<br />

The study <strong>on</strong> young men-not women-found that those receiving<br />

compounded progester<strong>on</strong>e were 50 percent less likely to die.<br />

There was less disability at the 1-m<strong>on</strong>th mark than would normally<br />

be expected c<strong>on</strong>sidering the severity of their head injuries.<br />

Marcus Baskett of Commerce, GA, was <strong>on</strong>e of those patients in<br />

a head-<strong>on</strong> automobile collisi<strong>on</strong> just 3 weeks shy of his high school<br />

graduati<strong>on</strong>. Early tests of his brain functi<strong>on</strong> suggested massive and<br />

disabling head injury.<br />

He spent almost 3 weeks in a coma. Then, 4 weeks later, Baskett<br />

was released with lingering physical injuries but little evidence of<br />

the severe head trauma. Three years later, a 21-year-old Baskett<br />

is back 100 percent.<br />

There are uses for compounded bioidentical horm<strong>on</strong>es that n<strong>on</strong>e<br />

of us have ever even imagined. To c<strong>on</strong>sider eliminating them is to<br />

limit the researchers' imaginati<strong>on</strong> everywhere.<br />

[The prepared statement of Ms. Wiley follows:]

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!